Are you Dr. Jarolim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-4725Fax+1 917-731-4872
Summary
- Dr. Petr Jarolim, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Brigham and Women's Hospital and is an Associate Professor of Pathology at Brigham and Women's Hospital.
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Blood Banking/Transfusion Medicine, 1996 - 1997- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1994 - 1997
Karlovy University FOMClass of 1983
Certifications & Licensure
MA State Medical License 1996 - 2025- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 37 citationsRelationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibit...Thomas A Zelniker, David A. Morrow, Ofri Mosenzon, Erica L. Goodrich, Petr Jarolim
European Journal of Heart Failure. 2021-06-01 - 36 citationsGrowth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.Eri Toda Kato, David A Morrow, Jianping Guo, David D Berg, Michael A Blazing
European Heart Journal. 2023-01-21 - 51 citationsT-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activityViviany R. Taqueti, Nir Grabie, Richard A. Colvin, Hong Pang, Petr Jarolim
Journal of Immunology. 2006-11-01
Authored Content
- Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesAugust 2020
Press Mentions
Community-Based Rapid NGS Offers Considerable Advantages in Clinical Cancer CareAugust 3rd, 2022
Serial NT-proBNP Found to Identify Risk for Adverse CV OutcomesAugust 17th, 2018
Elevated NT-proBNP Found to up Cardiovascular Risk in T2DMJune 15th, 2018- Join now to see all
